改良额肌腱膜瓣悬吊术治疗重度先天性上睑下垂的临床观察

Clinical observation of modified frontalis muscle suspension for severe congenital ptosis

目的对比观察改良额肌腱膜瓣悬吊术与传统额部悬吊术治疗重度先天性上睑下垂的临床疗效。方法将我院2008年3月至2012年3月收治的76例(87只眼)重度先天性上睑下垂患者按照不同手术方式分为治疗组(43例,行改良额肌腱膜瓣悬吊术)和对照组(33例,行传统额部悬吊术),对两组治疗效果进行综合比较。结果治疗组治愈率达到88.37%,明显高于对照组66.67%(P<0.05);随访1至3年,两组患者均未出现严重并发症。结论改良额肌腱膜瓣悬吊术治疗重度先天性上睑下垂的临床效果显著,优于传统额部悬吊术,值得临床推广应用。

Objective To compare the clinical efficacy between modified frontalis muscle suspension and frontal suspension in treating severe congenital ptosis .Methods We had 76 patients with severe congenital ptosis admitted to our hospital from March 2008 to March 2012.Patients were divided into treatment group （43 cases, received modified frontalis muscle suspension） and control group （33 cases, received frontal suspension ） and the efficacy of two groups were com-pared.Results The cure rate of treatment group was 88.37%, which was significantly higher than that of control group （ P 〈0.05）.After 1 to 3 years of follow-up, there were no serious complications in two groups .Conclusions Modified frontalis muscle suspension is significantly more effective to treat severe congenital ptosis than traditional frontal suspension .